Executive Vice President of $GM sells 4,459 shares in insider sale

In the latest insider trading news, Rory Harvey, the Executive Vice President of $GM, recently sold 4,459 shares of the company on 09-12-2025 for an estimated $267,317, according to a recent SEC filing. This sale accounted for about 34.4% of their total shares of this particular stock, leaving them with 8,513 shares of $GM stock in this class.

Over the past six months, $GM insiders have engaged in trading activities on the open market a total of 12 times. Out of these transactions, there have been no purchases and 12 sales. Among the notable insider trading activities within the last six months include Chair & CEO, Mary T Barra, who conducted 5 sales, Vice President & CAO, Christopher Hatto, who made 3 sales, and Executive Vice President, Rory Harvey, who carried out 4 sales.

Turning our attention to hedge fund activity, there have been significant movements observed with 509 institutional investors adding shares of $GM stock to their portfolio, while 833 have decreased their positions in the most recent quarter. Notable actions by major players in the hedge fund sector include Vanguard Group Inc adding 11,418,367 shares to their holdings, Viking Global Investors LP acquiring 5,830,050 shares, and BlackRock, Inc. reducing their position by 5,822,259 shares.

In the realm of congressional stock trading, members of Congress have engaged in trading $GM stock twice within the last six months, with one purchase and one sale. Representative Jefferson Shreve sold a sum of up to $50,000 on 05/12, while Representative Robert Bresnahan purchased up to $15,000 on 04/08.

On the analyst front, multiple Wall Street firms have issued reports regarding $GM, with 8 of them issuing buy ratings and 2 issuing sell ratings. Recent ratings include an “Outperform” rating from Wedbush, an “Underweight” rating from Wells Fargo, and a “Buy” rating from Citigroup.

Analysts have also provided price targets for $GM, with a median target of $60.0 based on 13 recent analysts’ forecasts. Notable price targets include $73.0 set by Dan Levy from Barclays and $65.0 set by Daniel Ives from Wedbush, offering valuable insights into potential future movements.

It is essential to note that this article does not constitute financial advice. For more information, refer to Quiver Quantitative’s disclaimers.